Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval
It will join Neos’ other ADHD drug, Adzenys XR-ODT, the company’s version of dextroamphetamine (Adderall XR), which was commercially launched in May 2016. Neos resubmitted its application for ...